Genotype-guided tacrolimus dosing in African-American kidney transplant recipients

K Sanghavi, RC Brundage, MB Miller… - The …, 2017 - nature.com
Tacrolimus is dependent on CYP3A5 enzyme for metabolism. Expression of the CYP3A5
enzyme is controlled by several alleles including CYP3A5* 1, CYP3A5* 3, CYP3A5* 6 and …

[PDF][PDF] Genotype-guided tacrolimus dosing in African-American kidney transplant recipients

K Sanghavi, RC Brundage, MB Miller… - The …, 2015 - researchgate.net
Kidney transplantation is a common and effective treatment for end-stage renal disease.
African Americans (AAs) represent∼ 34% of the candidates in the kidney transplant waiting …

Genotype-guided tacrolimus dosing in African-American kidney transplant recipients

K Sanghavi, RC Brundage, MB Miller… - Pharmacogenomics …, 2017 - experts.umn.edu
Tacrolimus is dependent on CYP3A5 enzyme for metabolism. Expression of the CYP3A5
enzyme is controlled by several alleles including CYP3A5∗ 1, CYP3A5∗ 3, CYP3A5∗ 6 and …

Genotype-guided tacrolimus dosing in African-American kidney transplant recipients

K Sanghavi, RC Brundage, MB Miller… - The …, 2017 - go.gale.com
Tacrolimus is dependent on CYP3A5 enzyme for metabolism. Expression of the CYP3A5
enzyme is controlled by several alleles including CYP3A5* 1, CYP3A5* 3, CYP3A5* 6 and …

[引用][C] Genotype-guided tacrolimus dosing in African-American kidney transplant recipients

K Sanghavi, RC Brundage, MB Miller… - The …, 2015 - cir.nii.ac.jp
Genotype-guided tacrolimus dosing in African-American kidney transplant recipients | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …

Genotype-guided tacrolimus dosing in African-American kidney transplant recipients

DEKAF Investigators - Pharmacogenomics Journal, 2017 - experts.nebraska.edu
Tacrolimus is dependent on CYP3A5 enzyme for metabolism. Expression of the CYP3A5
enzyme is controlled by several alleles including CYP3A5∗ 1, CYP3A5∗ 3, CYP3A5∗ 6 and …

Genotype-guided tacrolimus dosing in African-American kidney transplant recipients.

K Sanghavi, RC Brundage, MB Miller… - The …, 2015 - europepmc.org
Tacrolimus is dependent on CYP3A5 enzyme for metabolism. Expression of the CYP3A5
enzyme is controlled by several alleles including CYP3A5* 1, CYP3A5* 3, CYP3A5* 6 and …

Genotype-guided tacrolimus dosing in African-American kidney transplant recipients

K Sanghavi, RC Brundage, MB Miller… - The …, 2017 - pubmed.ncbi.nlm.nih.gov
Tacrolimus is dependent on CYP3A5 enzyme for metabolism. Expression of the CYP3A5
enzyme is controlled by several alleles including CYP3A5* 1, CYP3A5* 3, CYP3A5* 6 and …

[HTML][HTML] Genotype-guided tacrolimus dosing in African American kidney transplant recipients

K Sanghavi, RC Brundage, MB Miller… - The …, 2017 - ncbi.nlm.nih.gov
Tacrolimus is dependent on CYP3A5 enzyme for metabolism. Expression of the CYP3A5
enzyme is controlled by several alleles including CYP3A5* 1, CYP3A5* 3, CYP3A5* 6 and …

[PDF][PDF] Genotype-guided tacrolimus dosing in African-American kidney transplant recipients

K Sanghavi, RC Brundage, MB Miller… - The …, 2015 - researchgate.net
Kidney transplantation is a common and effective treatment for end-stage renal disease.
African Americans (AAs) represent∼ 34% of the candidates in the kidney transplant waiting …